Cite
MLA Citation
Jaroslaw Kierkus et al.. “Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.” Crohn's & colitis 360, vol. 2, no. 3, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100117137666.0x000006